Medtronic

2091 articles with Medtronic

• Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases

  5/16/2019

  FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons

• Q3 Medical Devices Limited Enters into a Distribution Agreement with Medtronic for its Biodegradable Biliary and Pancreatic Stent

  5/15/2019

  Q3 Medical Devices Limited based in Dublin, Ireland, announced that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the first to market fully biodegradable biliary and pancreatic stent designed as an alternative to traditional plastic stents.

• Medtronic Reveals Results of First-In-Human Study for Investigational Extravascular ICD System

  5/11/2019

  Medtronic plc announced findings from a pilot study of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system, in which a lead is placed outside of the heart and veins to deliver lifesaving defibrillation and anti-tachycardia pacing therapy in one system, with a device the same size as traditional, transvenous ICDs.

• New Studies Highlight Underuse of Implantable Cardiac Devices

  5/10/2019

  Treatment Disparities Prevent Indicated Patients from Receiving

• Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year 2019

  5/10/2019

  Medtronic plc announced today that it will report financial results for its fourth quarter and fiscal year 2019 on Thursday, May 23, 2019.

• New Study Demonstrates Safety and Effectiveness of the MiniMed(TM) 640G System Reducing Hypoglycemia Compared with Insulin Pump Therapy Without CGM in Type 1 Diabetes

  5/9/2019

  Medtronic plc announced the publication of the SMILE study in The Lancet Diabetes & Endocrinology.

• Medtronic Enters Into Definitive Agreement to Acquire Titan Spine

  5/9/2019

  Acquisition Further Accelerates Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions

• Prospective Data Demonstrates Effective Pain Relief and Improved Function Using Medtronic's Evolve(SM) Workflow with Spinal Cord Stimulation

  5/7/2019

  To Assess the Potential of Non-Opioid Treatment Options for Chronic Pain, Study Evaluates Pain Relief, Patient Function and Satisfaction

• PROSPECTIVE DATA DEMONSTRATES EFFECTIVE PAIN RELIEF AND IMPROVED FUNCTION USING MEDTRONIC’S EVOLVESM WORKFLOW WITH SPINAL CORD STIMULATION

  5/7/2019

  Medtronic plc (NYSE:MDT) today announced primary endpoint (3-month) results of the Vectors Post Market Clinical Study that demonstrated effective pain relief and improved function in patients with chronic intractable back and leg pain treated with spinal cord stimulation (SCS) utilizing the EvolveSM workflow*

• Medtronic Receives FDA Approval for CareLink SmartSync Device Manager

  5/2/2019

  Tablet-Based Device Manager Provides Portable and Secure Wireless Programming of Medtronic BlueSync(TM) Devices

• Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

  5/1/2019

  Attain Stability(TM) Quad MRI SureScan(TM) Lead Designed for Precise Placement and Stability

• Medtronic Announces U.S. Commercial Launch of Solitaire(TM) X Revascularization Device

  4/30/2019

  System Offers New Options for Improving Outcomes in Treating Stroke

• Medtronic Data Expands on Key Aortic Solutions for Challenging Anatomies

  4/17/2019

  New EndoSuture Aneurysm Repair (ESAR) and Valiant Navion(TM) Data Presented at Charing Cross Demonstrate Safety and Efficacy in Patients with Complex Anatomies

• Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease

  4/17/2019

  Medtronic plc announced five-year outcomes from the VeClose Extension Study.

• New Data Show Encouraging Economic Outcomes for Medtronic HeartWare(TM) HVAD(TM) System

  4/8/2019

  Positive HVAD LATERALTM Study Results Also Now Published in The Journal of Heart and Lung Transplantation

• Medtronic HeartWare(TM) HVAD(TM) System Demonstrates Reduction in Total Strokes, Disabling Strokes and Stroke-Related Mortality with Blood Pressure Management

  4/5/2019

  Company Has Initiated a Post-Approval Study of Heart Failure Management Best Practices to Further Demonstrate Improved Patient Outcomes

• Medtronic Launches Medtech Innovation Accelerator in Shanghai

  3/25/2019

  Early-Stage Business Accelerator to Empower Local MedTech Innovation and Enhance Medtronic China's Industry Leadership

• New Clinical Trial Shows Medtronic TYRX(TM) Envelope Signficantly Reduces Major Infections in Cardiac Implantable Device Patients

  3/17/2019

  WRAP-IT is the Largest Randomized Global Trial Ever Conducted with Cardiac Implanted Electronic Devices

• Medtronic Evolut Low Risk Trial Meets Primary Endpont

  3/16/2019

  Less Invasive Evolut(TM) Transcatheter Aortic Valve Replacement (TAVR) System Successful in Clinical Trial When Compared to Open Heart Surgery in Healthier Aortic Stenosis Patients

• 

  ACC Preview: Apple Watch, Cardiac Device Trials, Keto Diet and More

  3/15/2019

  As the American College of Cardiology (ACC) annual meeting opens in New Orleans this weekend, one of the big stories will undoubtedly be on the role of wrist sensors, such as the Apple Watch, in identifying heart rhythm problems. There will be other big stories, of course. Here’s a preview of jus...